Patent 11993658 was granted and assigned to Sutro Biopharma on May, 2024 by the United States Patent and Trademark Office.
The present disclosure relates to antibodies that selectively bind to B-cell maturation antigen (BCMA) and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.